Presenting new epidemiological and diabetes-related impact data.
IDF is delighted to announce the appointment of Professors Dianna Magliano and Edward Boyko to lead the development and publication of the 10th edition of the IDF Diabetes Atlas in 2021.
Professor Magliano is based in Australia, where she heads the Diabetes and Population Health group at the Baker Heart and Diabetes Institute in Melbourne. She has a BAppSci (Hons), PhD and a Master’s in Public Health.
Professor Magliano has worked as an epidemiologist for over 15 years. The majority of her research has been in diabetes, obesity and cardiovascular disease. She is currently leading an international collaboration funded by the US Centers for Disease Control and Prevention, which has involved the assembly and analysis of over 23 national population-based datasets to understand global trends of diabetes incidence and mortality. Professor Magliano is the secretary for the International Diabetes Epidemiology Group and was the organisation’s president from 2015 - 2017.
Professor Edward Boyko MD, MPH, is Professor of Medicine and Adjunct Professor of Epidemiology at the University of Washington and Staff Physician at VA Puget Sound Health Care System in Seattle. He is the founding and former Director of the Seattle Epidemiologic Research and Information Center. Professor Boyko’s work is widely published. His research focuses on the epidemiology of type 2 diabetes and its complications, associated metabolic disorders, and obesity. He has held a number of national and international positions.
Professor Boyko is no stranger to IDF. He was a deputy stream lead for the IDF World Diabetes Congress 2013 in Melbourne, epidemiology and public health stream lead for the IDF World Diabetes Congress 2015 in Vancouver and, most recently, the Programme Chair for the IDF Congress 2019 in Busan, Korea. He has also been involved with the IDF Diabetes Atlas since its 8th edition.
What can we expect from the 10th Edition?
As the 10th edition of the IDF Diabetes Atlas will be published next year to coincide with the 100th anniversary of the discovery of insulin, it will dedicate a section to the issues around access to insulin in different parts of the world.
Several other new or expanded topics are under consideration. The team hope to deliver more specific estimates for type 1 diabetes in adults. Type 2 diabetes in children and youth will receive greater focus. Given the current coronavirus pandemic and emerging body of research into COVID-19 and diabetes, the team intend to dedicate an Atlas section to this topic.
The new Chairs welcome suggestions for new thematic areas to explore in this or future editions. If you have a suggestion, please share your thoughts by email to firstname.lastname@example.org.
What is happening in the project right now?
Work on the 10th edition kicked off at the beginning of May. Currently, under the leadership of the new Chairs, the team are bringing together a panel of global diabetes experts to serve on the IDF Diabetes Atlas Committee and recruiting a network of researchers to join the Special Interest Groups to help develop the thematic chapters. The next step will be to collect new data in diabetes to deliver the best possible estimates and figures based on the research currently available. In parallel, IDF is developing an epidemiology guide and training materials to support researchers in the collection of diabetes data. The goal is to encourage data collection in countries where we lack knowledge.
A decade ago, the global projection for the number of people who would be living with diabetes in 2025 was 438 million. With over five years still to go, that prediction has been surpassed by 25 million. Meaningful change is needed to manage the rising tide of diabetes, prevent the onset of diabetes in the many millions at high risk and provide care for the millions living with diabetes today. IDF will develop a new version of the IDF Diabetes Atlas Advocacy Guide and other material to help the global diabetes community use Atlas data to elevate the issue of diabetes onto national and global political agendas.
Learn more about the latest diabetes figures by exploring the IDF Diabetes Atlas website at www.diabetesatlas.org.